These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 10789192)

  • 1. [The role of cellular glucose transporters in pathogenesis of diabetic nephropathy].
    Witowski J; Breborowicz A
    Przegl Lek; 1999; 56(12):793-9. PubMed ID: 10789192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose transporters of the glomerulus and the implications for diabetic nephropathy.
    Heilig CW; Brosius FC; Henry DN
    Kidney Int Suppl; 1997 Sep; 60():S91-9. PubMed ID: 9285909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose transporters in diabetic nephropathy.
    Brosius FC; Heilig CW
    Pediatr Nephrol; 2005 Apr; 20(4):447-51. PubMed ID: 15717166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypic and functional alterations of mesangial cells in patients with diabetic nephropathy].
    Liu Z; Chen Z; Li Y
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1369-73. PubMed ID: 11930630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for GLUT1 in diabetic glomerulosclerosis.
    Heilig CW; Brosius FC; Cunningham C
    Expert Rev Mol Med; 2006 Feb; 8(4):1-18. PubMed ID: 16515729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modulatory effect of transforming growth factor-beta and Rhein on glucose transporter-1 in human glomerular mesangial cells].
    Liu Z; Li Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):780-3. PubMed ID: 11715528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rhein on glucose transporter-1 expression and its function in glomerular mesangial cells.
    Zhang J; Liu Z; Chen Z; Li Y; Li L
    Chin Med J (Engl); 1999 Dec; 112(12):1077-9. PubMed ID: 11721442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the GLUT8 glucose transporter in murine kidney and regulation in vivo in nondiabetic and diabetic conditions.
    Schiffer M; Susztak K; Ranalletta M; Raff AC; Böttinger EP; Charron MJ
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F186-93. PubMed ID: 15741607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S; Nyengaard JR; Wogensen L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells].
    Zhang J; Liu Z; Liu H; Li Y; Li L
    Chin Med J (Engl); 2000 Jun; 113(6):508-13. PubMed ID: 11775867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
    Ahn JD; Morishita R; Kaneda Y; Kim HJ; Kim YD; Lee HJ; Lee KU; Park JY; Kim YH; Park KK; Chang YC; Yoon KH; Kwon HS; Park KG; Lee IK
    Gene Ther; 2004 Jun; 11(11):916-23. PubMed ID: 14961072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TGF-beta/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model.
    Ricci C; Iacobini C; Oddi G; Amadio L; Menini S; Rastaldi MP; Frasheri A; Pricci F; Pugliese F; Pugliese G
    Nephrol Dial Transplant; 2006 Jun; 21(6):1514-24. PubMed ID: 16449286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism.
    Gnudi L; Thomas SM; Viberti G
    J Am Soc Nephrol; 2007 Aug; 18(8):2226-32. PubMed ID: 17634438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
    Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
    Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport.
    Solini A; Chiozzi P; Morelli A; Passaro A; Fellin R; Di Virgilio F
    J Cell Physiol; 2003 Dec; 197(3):435-44. PubMed ID: 14566973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney.
    Ha H; Lee HB
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S7-10. PubMed ID: 16174288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose transporters control gene expression of aldose reductase, PKCalpha, and GLUT1 in mesangial cells in vitro.
    Henry DN; Busik JV; Brosius FC; Heilig CW
    Am J Physiol; 1999 Jul; 277(1):F97-104. PubMed ID: 10409302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic exposure of human glomerular epithelial cells to high glucose concentration results in modulation of high-affinity glucose transporters expression.
    Moutzouris DA; Kitsiou PV; Talamagas AA; Drossopoulou GI; Kassimatis TI; Katsilambros NK
    Ren Fail; 2007; 29(3):353-8. PubMed ID: 17497451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.